Methyl 2,3-dibromopropionate | CAS:1729-67-5

We serve Methyl 2,3-dibromopropionate CAS:1729-67-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Methyl 2,3-dibromopropionate

Chemical Name:Methyl 2,3-dibromopropionate
CAS.NO:1729-67-5
Synonyms:Propanoic acid, 2,3-dibromo-, methyl ester
Molecular Formula:C4H6Br2O2
Molecular Weight:245.89700
 
Physical and Chemical Properties:
Density:1.944;
Melting point:8oC;
Boiling point:83-86oC;
Flash point:-33oC;
Index of Refraction:1.514;
 
Specification:
Appearance:Colorless to pale yellow transparent liquid
Purity(GC):≥98.0%
Moisture:≤0.1%
 
Packing:250 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:As an intermediate in organic synthesis
 



Contact us for information like Methyl 2,3-dibromopropionate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Propanoic acid, 2,3-dibromo-, methyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Propanoic acid, 2,3-dibromo-, methyl ester Use and application,Methyl 2,3-dibromopropionate technical grade,usp/ep/jp grade.


Related News: In 2004, the National Development and Reform Commission, the former Ministry of Health, and the Ministry of Finance jointly formulated and promulgated the Administrative Measures for the Configuration and Use of Large Medical Equipment. This method uses X-ray electronic computer tomography (CT) devices and medical magnetic resonance imaging equipment, digital subtraction angiography X-ray machines of 800 mA or more as the management products of large-scale medical equipment, Purchase and use need to be reported to the provincial health administrative department for approval before approval. However, in recent years, with the comprehensive coverage of medical insurance, such basic medical facilities are being widely popularized, and the relevant implementation rules have directly linked the number of equipment to the number of doctors. Therefore, as the demand for imaging equipment continues to increase, it will have a greater boosting effect on the upstream contrast agent and its raw material market.2,6-Dichloroaniline manufacturer In 2004, the National Development and Reform Commission, the former Ministry of Health, and the Ministry of Finance jointly formulated and promulgated the Administrative Measures for the Configuration and Use of Large Medical Equipment. This method uses X-ray electronic computer tomography (CT) devices and medical magnetic resonance imaging equipment, digital subtraction angiography X-ray machines of 800 mA or more as the management products of large-scale medical equipment, Purchase and use need to be reported to the provincial health administrative department for approval before approval. However, in recent years, with the comprehensive coverage of medical insurance, such basic medical facilities are being widely popularized, and the relevant implementation rules have directly linked the number of equipment to the number of doctors. Therefore, as the demand for imaging equipment continues to increase, it will have a greater boosting effect on the upstream contrast agent and its raw material market.Diphenyl(piperidin-4-yl)methanol supplier Our pharma and biotech offering includes registration and commercialization of products through in-licensing and flexible partnerships.1-IODO-3-FLUOROPROPANE vendor At the same time, through years of imitation and advanced technology learning, more and more domestic companies have participated in the field of highly original and characteristic APIs.As a result, the Company’s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy.